SAGE Open Medicine · 2023 · 11 citations · 22 references
Our findings suggest that repetitive transcranial magnetic stimulation is a safe and effective therapeutic approach for ameliorating peripheral nerve injury and alleviating the chemotherapy-induced peripheral neuropathy symptoms in multiple myeloma patients. Early initiation of repetitive transcranial magnetic stimulation treatment may yield more favorable outcomes for these patients.
22
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1K citations · Full text
Brian G.M. Durie, Antje Hoering, Muneer H. Abidi et al. · The Lancet · 2016 · 868 citations · Full text
Hematological Malignancy, Dexamethasone Versus Lenalidomide, Oncology +9
Trends in overall survival and costs of multiple myeloma, 2000–2014
Rafaël Fonseca, Safiya Abouzaid, Machaon Bonafede et al. · Leukemia · 2016 · 326 citations · Full text